FDA OKs Once-Nightly Lumryz for Children With Narcolepsy

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Lumryz is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness in children as young as 7 years with narcolepsy.
Medscape Medical News